Literature DB >> 26113369

The Emergency Medicine Debate on tPA for Stroke: What Is Best for Our Patients? Efficacy in the First Three Hours.

Joseph B Miller1, Laura Heitsch2, Matthew S Siket3, Jon W Schrock4, Charles R Wira5, Christopher Lewandowski6, Tracy E Madsen3, Lisa H Merck3, David W Wright7.   

Abstract

Entities:  

Year:  2015        PMID： 26113369     DOI： 10.1111/acem.12712

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN： 1069-6563            Impact factor:   3.451


× No keyword cloud information.
  2 in total

1.  Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over Placebo.

Authors:  Shashank Agarwal; Erica Scher; Aaron Lord; Jennifer Frontera; Koto Ishida; Jose Torres; Sara Rostanski; Eva Mistry; Brian Mac Grory; Shawna Cutting; Tina Burton; Brian Silver; Ava L Liberman; Mackenzie P Lerario; Karen Furie; James Grotta; Pooja Khatri; Jeffrey Saver; Shadi Yaghi
Journal:  Stroke       Date:  2020-02-27       Impact factor: 7.914

2.  MiR-340 Regulates Fibrinolysis and Axon Regrowth Following Sciatic Nerve Injury.

Authors:  Shiying Li; Ruirui Zhang; Ying Yuan; Sheng Yi; Qianqian Chen; Leilei Gong; Jie Liu; Fei Ding; Zheng Cao; Xiaosong Gu
Journal:  Mol Neurobiol       Date:  2016-06-25       Impact factor: 5.590
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.